Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting, 66716-66717 [2022-24087]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
66716
Federal Register / Vol. 87, No. 213 / Friday, November 4, 2022 / Notices
Official for the BSC, Office of Policy,
Review, and Outreach, Division of
Translational Toxicology, NIEHS.
Phone: 984–287–3364, Email:
milene.brownlow@nih.gov. Hand
Deliver/Courier address: 530 Davis
Drive, Room K2161, Durham, NC 27713.
SUPPLEMENTARY INFORMATION: The BSC
will provide input to the NTP on
programmatic activities and issues. The
preliminary agenda topics include
presentations on three contract
concepts: Chemistry, Toxicology, and
Pathology Support Services for the
NIEHS. The preliminary agenda, roster
of BSC members, background materials,
public comments, and any additional
information, when available, will be
posted on the BSC meeting web page
(https://ntp.niehs.nih.gov/go/165) or
may be requested in hardcopy from the
Designated Federal Official for the BSC.
Following the meeting, summary
minutes will be prepared and made
available on the BSC meeting web page.
Meeting Attendance Registration: The
meeting is open to the public with time
scheduled for oral public comments.
Registration is not required to view the
virtual meeting; the URL for the virtual
meeting is provided on the BSC meeting
web page (https://ntp.niehs.nih.gov/go/
165), the day before the meeting. TTY
users should contact the Federal TTY
Relay Service at 800–877–8339.
Requests should be made at least five
business days in advance of the event.
Written Public Comments: NTP
invites written public comments.
Guidelines for public comments are
available at https://ntp.niehs.nih.gov/
ntp/about_ntp/guidelines_public_
comments_508.pdf.
The deadline for submission of
written comments is December 08, 2022.
Written public comments should be
submitted through the meeting web
page. Persons submitting written
comments should include name,
affiliation, mailing address, phone,
email, and sponsoring organization (if
any). Written comments received in
response to this notice will be posted on
the NTP web page, and the submitter
will be identified by name, affiliation,
and sponsoring organization (if any).
Oral Public Comment Registration:
The agenda allows for public comment
periods on the agenda topics (up to five
commenters per topic, up to five
minutes per speaker per topic). Persons
wishing to make an oral comment are
required to register online at https://
ntp.niehs.nih.gov/go/165 by December
08, 2022. Oral comments will be
received only during the formal
comment periods indicated on the
preliminary agenda. Registration is on a
VerDate Sep<11>2014
18:12 Nov 03, 2022
Jkt 259001
first-come, first-served basis. Each
organization is allowed one time slot
per topic. After the maximum number of
speakers is exceeded, individuals
registered to provide oral comment will
be placed on a wait list and notified
should an opening become available.
Commenters will be notified
approximately one week before the
meeting to provide logistical
information for their presentations. If
possible, oral public commenters should
send a copy of their slides and/or
statement or talking points to Ms.
Robbin Guy by email: robbin.guy@
nih.gov by December 08, 2022.
Meeting Materials: The preliminary
meeting agenda will be available on the
meeting web page (https://ntp.niehs.
nih.gov/go/165) by November 10, 2022
and updated one week before the
meeting. Individuals are encouraged to
access the meeting web page to stay
abreast of the most current information
regarding the meeting.
Background Information on the BSC:
The BSC is a technical advisory body
comprised of scientists from the public
and private sectors that provides
primary scientific oversight to the NTP.
Specifically, the BSC advises the NTP
on matters of scientific program content,
both present and future, and conducts
periodic review of the program for the
purpose of determining and advising on
the scientific merit of its activities and
their overall scientific quality. Its
members are selected from recognized
authorities knowledgeable in fields such
as toxicology, pharmacology, pathology,
epidemiology, risk assessment,
carcinogenesis, mutagenesis, cellular
biology, computational toxicology,
neurotoxicology, genetic toxicology,
reproductive toxicology or teratology,
and biostatistics. Members serve
overlapping terms of up to four years.
The BSC usually meets periodically.
The authority for the BSC is provided by
42 U.S.C. 217a, section 222 of the Public
Health Service Act (PHS), as amended.
The BSC is governed by the
provisions of the Federal Advisory
Committee Act, as amended (5 U.S.C.
app.), which sets forth standards for the
formation and use of advisory
committees.
Dated: October 31, 2022.
Brian R. Berridge,
Associate Director, National Toxicology
Program.
[FR Doc. 2022–24000 Filed 11–3–22; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Diabetes Mellitus Interagency
Coordinating Committee Meeting
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The Diabetes Mellitus
Interagency Coordinating Committee
(DMICC) will hold a meeting on
December 12, 2022. The topic for this
meeting will be ‘‘NIDDK’s Office of
Obesity Research: Evolving Concepts in
the Heterogeneity of Obesity’’. The
meeting is open to the public.
DATES: The meeting will be held on
December, 12 2022 from 1:00 p.m. to
4:00 p.m. EST.
ADDRESSES: The meeting will be held
via the Zoom online video conferencing
platform. For details, and to register,
please contact dmicc@mail.nih.gov.
FOR FURTHER INFORMATION CONTACT: For
further information concerning this
meeting, including a draft agenda,
which will be posted when available,
see the DMICC website,
www.diabetescommittee.gov, or contact
Dr. William Cefalu, Executive Secretary
of the Diabetes Mellitus Interagency
Coordinating Committee, National
Institute of Diabetes and Digestive and
Kidney Diseases, 6707 Democracy
Boulevard, Democracy 2, Room 6037,
Bethesda, MD 20892, telephone: 301–
435–1011; email: dmicc@mail.nih.gov.
SUPPLEMENTARY INFORMATION: In
accordance with 42 U.S. Code 285c–3,
the DMICC, chaired by the National
Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK) comprising
members of the Department of Health
and Human Services and other federal
agencies that support diabetes-related
activities, facilitates cooperation,
communication, and collaboration on
diabetes among government entities.
DMICC meetings, held several times a
year, provide an opportunity for
Committee members to learn about and
discuss current and future diabetes
programs in DMICC member
organizations and to identify
opportunities for collaboration. The
December 12, 2022 DMICC meeting will
focus on ‘‘NIDDK’s Office of Obesity
Research: Evolving Concepts in the
Heterogeneity of Obesity.’’
Any member of the public interested
in presenting oral comments to the
Committee should notify the contact
person listed on this notice at least 5
days in advance of the meeting.
Interested individuals and
SUMMARY:
E:\FR\FM\04NON1.SGM
04NON1
Federal Register / Vol. 87, No. 213 / Friday, November 4, 2022 / Notices
representatives or organizations should
submit a letter of intent, a brief
description of the organization
represented, and a written copy of their
oral presentation in advance of the
meeting. Only one representative of an
organization will be allowed to present;
oral comments and presentations will be
limited to a maximum of 5 minutes.
Printed and electronic copies are
requested for the record. In addition,
any interested person may file written
comments with the Committee by
forwarding their statement to the
contact person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Because of time constraints for the
meeting, oral comments will be allowed
on a first-come, first-serve basis.
Members of the public who would
like to receive email notification about
future DMICC meetings should register
for the listserv available on the DMICC
website, www.diabetescommittee.gov.
William T. Cefalu,
Director, Division of Diabetes, Endocrinology,
and Metabolic Diseases, National Institute of
Diabetes and Digestive and Kidney Diseases,
and Metabolic Diseases, National Institutes
of Health.
[FR Doc. 2022–24087 Filed 11–3–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel, Small
Business: Biological Chemistry,
Biophysics, and Assay Development,
November 15–16, 2022, 9:00 a.m. to 5:00
p.m., The Bethesdan Hotel Tapestry
Collection by Hilton (Formerly Holiday
Inn Select), 8120 Wisconsin Avenue,
Bethesda, MD 20814, which was
published in the Federal Register on
October 20, 2022, 87 FR 63790, Doc
2022–22763.
This meeting is being amended to
change the meeting start time from 9:00
a.m. to 8:30 a.m. The meeting is closed
to the public.
Dated: November 1, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–24061 Filed 11–3–22; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:12 Nov 03, 2022
Jkt 259001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Immunology and Infectious
Diseases C.
Date: December 1–2, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shannon J. Sherman,
Ph.D., Scientific Review Officer, The Center
for Scientific Review, The National Institutes
of Health, 6701 Rockledge Drive, Bethesda,
MD 20892, 301–594–0715,
shannon.sherman@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Special
Topics in Biomaterials, Biointerfaces, Gene
and Drug Delivery.
Date: December 2, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Joseph D. Mosca, BA,
Ph.D., MBA, Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 5158, MSC 7808, Bethesda, MD 20892,
(301) 408–9465, moscajos@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR:
Maternal and Pediatric Pharmacology and
Therapeutics.
Date: December 2, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dianne Hardy, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
66717
Health, 6701 Rockledge Drive, Room 6175,
MSC 7892, Bethesda, MD 20892, 301–435–
1154, dianne.hardy@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 31, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–24033 Filed 11–3–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Division of Intramural
Research Board of Scientific Counselors,
NIAID.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
NATIONAL INSTITUTE OF ALLERGY
AND INFECTIOUS DISEASES,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Division of Intramural
Research Board of Scientific Counselors,
NIAID.
Date: December 12–14, 2022.
Time: 7:45 a.m. to 10:15 a.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, Building 50, Conference Room 1227/
1233, 50 Center Drive, Bethesda, MD 20892.
Contact Person: Laurie Lewallen,
Committee Manager, Division of Intramural
Research Program Support Staff, National
Institute of Allergy and Infectious Diseases,
National Institutes of Health, Building 33,
Room 1N24, 33 North Drive, Bethesda, MD
20892, 301–761–6362, Laurie.Lewallen@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
E:\FR\FM\04NON1.SGM
04NON1
]]>Agencies
[Federal Register Volume 87, Number 213 (Friday, November 4, 2022)]
[Notices]
[Pages 66716-66717]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-24087]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Diabetes Mellitus Interagency Coordinating Committee
Meeting
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Diabetes Mellitus Interagency Coordinating Committee
(DMICC) will hold a meeting on December 12, 2022. The topic for this
meeting will be ``NIDDK's Office of Obesity Research: Evolving Concepts
in the Heterogeneity of Obesity''. The meeting is open to the public.
DATES: The meeting will be held on December, 12 2022 from 1:00 p.m. to
4:00 p.m. EST.
ADDRESSES: The meeting will be held via the Zoom online video
conferencing platform. For details, and to register, please contact
[email protected].
FOR FURTHER INFORMATION CONTACT: For further information concerning
this meeting, including a draft agenda, which will be posted when
available, see the DMICC website, www.diabetescommittee.gov, or contact
Dr. William Cefalu, Executive Secretary of the Diabetes Mellitus
Interagency Coordinating Committee, National Institute of Diabetes and
Digestive and Kidney Diseases, 6707 Democracy Boulevard, Democracy 2,
Room 6037, Bethesda, MD 20892, telephone: 301-435-1011; email:
[email protected].
SUPPLEMENTARY INFORMATION: In accordance with 42 U.S. Code 285c-3, the
DMICC, chaired by the National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK) comprising members of the Department of Health
and Human Services and other federal agencies that support diabetes-
related activities, facilitates cooperation, communication, and
collaboration on diabetes among government entities. DMICC meetings,
held several times a year, provide an opportunity for Committee members
to learn about and discuss current and future diabetes programs in
DMICC member organizations and to identify opportunities for
collaboration. The December 12, 2022 DMICC meeting will focus on
``NIDDK's Office of Obesity Research: Evolving Concepts in the
Heterogeneity of Obesity.''
Any member of the public interested in presenting oral comments to
the Committee should notify the contact person listed on this notice at
least 5 days in advance of the meeting. Interested individuals and
[[Page 66717]]
representatives or organizations should submit a letter of intent, a
brief description of the organization represented, and a written copy
of their oral presentation in advance of the meeting. Only one
representative of an organization will be allowed to present; oral
comments and presentations will be limited to a maximum of 5 minutes.
Printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
Committee by forwarding their statement to the contact person listed on
this notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person. Because of time constraints for the meeting,
oral comments will be allowed on a first-come, first-serve basis.
Members of the public who would like to receive email notification
about future DMICC meetings should register for the listserv available
on the DMICC website, www.diabetescommittee.gov.
William T. Cefalu,
Director, Division of Diabetes, Endocrinology, and Metabolic Diseases,
National Institute of Diabetes and Digestive and Kidney Diseases, and
Metabolic Diseases, National Institutes of Health.
[FR Doc. 2022-24087 Filed 11-3-22; 8:45 am]
BILLING CODE 4140-01-P
